BioInnovation Institute

BioInnovation Institute is an incubator and venture capital firm based in Copenhagen, Denmark, founded in November 2018. It specializes in supporting early-stage startups within the life sciences sector, focusing on areas such as medical technology, pharmaceuticals, health tech, therapeutics, bio-industrials, and biotechnology. The firm aims to foster innovation by providing financial backing, typically investing up to €1.3 million per startup and €2.4 million per project. BioInnovation Institute offers valuable resources and support to entrepreneurs and researchers, facilitating the development of transformative solutions in the life sciences.

Bobby G. Soni

Chief Business Officer

Past deals in Nordic Europe

Enduro

Pre Seed Round in 2020
Enduro Genetics is a technology provider that specializes in enhancing large-scale fermentations through its proprietary synthetic biology technology. The company focuses on improving the performance of fermentation processes by developing a genetic plugin technology that is free of antibiotic resistance genes. This innovation allows for higher yields by enriching spontaneous high producers within the fermentation population, facilitating the production of complex or cellular inhibit products by addressing strain instability. By maximizing the performance of cells derived from production strains, Enduro aims to bolster the competitiveness of both current and future green bioproduction initiatives.

Sundew

Seed Round in 2020
Sundew ApS is a biotechnology company based in Copenhagen, Denmark, focused on developing biology-based technology platforms for the treatment of aquatic pests and diseases. Founded in 2018, Sundew aims to create innovative products that address the challenges posed by these environmental issues. The company leverages its expertise in biological sciences to offer effective solutions for pest management in aquatic ecosystems.

Paragit

Grant in 2020
Paragit Solutions is focused on improving the assessment of motor symptoms related to Parkinson's disease and enhancing the evaluation of new therapies. The company has developed a healthcare tracking device that employs artificial intelligence to monitor and quantify these symptoms. This device consists of a sleeve that records daily routine data, which is then stored in cloud storage. By enabling neurologists to access this data, Paragit facilitates more accurate treatment decisions for patients suffering from Parkinson's disease. This innovative approach aims to transform how patients are medicated and how their conditions are managed.

Cirqle Biomedical

Pre Seed Round in 2019
Cirqle Biomedical is a biotech company developing a non-hormonal contraceptive technology for women based on the principles of mucus engineering. Our lab and offices are based in Copenhagen, Denmark.

RetiPharma

Venture Round in 2018
RetiPharma is a biotechnology company based in Copenhagen, Denmark, focused on developing treatments for degenerative eye disorders using peptide-based products. The company's portfolio includes RP001, a peptide drug designed for intravitreal injection, alongside additional peptide drugs RP002 and RP003. These products aim to provide neuroprotective effects within the eye, addressing significant medical needs in ophthalmology.